Sofia 2 Flu+SARS Antigen FIA Test For use with Sofia 2 - FDA Emergency Use AuthorizationThe Sofia 2 Flu + SARS Antigen Fluorescent Immunoassay (FIA) uses advanced immunofluorescence-based lateral flow technology in a sandwich design for qualitative detection of nucleocapsid protein from influenza A and influenza B, and SARS-CoV-2. The Sofia 2 Flu + SARS Antigen FIA with the Sofia 2 analyzer provides automated and objective results in 15 minutes, allowing for testing of patients suspected of influenza A, influenza B, and COVID-19/2019-nCoV at the Point of Care.
One sample, three resultsResults in 15 minutesObjective, accurate results: Reliable results without cross-reactivity to seasonal coronaviruses.Fluorescent technology with automated readIncludes nasal swabsMust be used with Sofia 2 analyzer